United Therapeutics | UTHR - Net Income


United Therapeutics reported $338.7M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Amarin USD -7.74M 6.4M Sep/2025
Ardelyx USD -969K 18.11M Sep/2025
Baxter International USD -46M 137M Sep/2025
Bayer EUR -963M 764M Sep/2025
Biogen USD 466.5M 168.3M Sep/2025
BioMarin Pharmaceutical USD -30.74M 271.28M Sep/2025
Gilead Sciences USD 3.05B 1.09B Sep/2025
GlaxoSmithKline GBP 2.01B 570M Sep/2025
Halozyme Therapeutics USD 175.22M 10.06M Sep/2025
Insmed USD -370.02M 48.34M Sep/2025
Ionis Pharmaceuticals USD -128.61M 252.16M Sep/2025
J&J USD 5.12B 36M Dec/2025
Moderna USD -200M 625M Sep/2025
Pfizer USD 3.54B 631M Sep/2025
PTC Therapeutics USD 15.9M 80.75M Sep/2025
Regeneron Pharmaceuticals USD 844.6M 615.4M Dec/2025
Sarepta Therapeutics USD -179.95M 376.84M Sep/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025
United Therapeutics USD 338.7M 29.2M Sep/2025
Vertex Pharmaceuticals USD 1.08B 50M Sep/2025